Get the Stockscreener App
466.46
0.30%
-1.40
Pre-market:
464.66
-1.80
-0.39%
Overview
News
Price History
Option Chain
Financials
Why HCA Down?
Discussions
Forecast
Dividend History
Hca Healthcare Inc stock is traded at $466.46, with a volume of 1.49M.
It is down -0.30% in the last 24 hours and up +11.31% over the past month.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
See More
Previous Close:
$467.86
Open:
$466.33
24h Volume:
1.49M
Relative Volume:
1.15
Market Cap:
$109.15B
Revenue:
$74.37B
Net Income/Loss:
$7.31B
P/E Ratio:
18.03
EPS:
25.8765
Net Cash Flow:
$8.10B
1W Performance:
+7.97%
1M Performance:
+11.31%
6M Performance:
+40.49%
1Y Performance:
+30.81%
1-Day Range:
$454.46
$467.04
1-Week Range:
$424.00
$469.18
52-Week Range:
$289.98
$469.18
Hca Healthcare Inc Stock (HCA) Company Profile
Name
Hca Healthcare Inc
Sector
Industry
Phone
(615) 344-9551
Address
ONE PARK PLZ, NASHVILLE, TN
Compare HCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
466.46 | 109.48B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
204.62 | 19.10B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.09 | 15.96B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
126.28 | 12.81B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
219.32 | 13.62B | 16.08B | 1.20B | 1.06B | 17.82 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Resumed | Goldman | Buy |
| Jul-28-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-16-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-29-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Nov-22-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-03-24 | Initiated | Morgan Stanley | Equal-Weight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-04-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Resumed | JP Morgan | Neutral |
| Jul-06-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-29-22 | Initiated | Wells Fargo | Equal Weight |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-13-21 | Resumed | Citigroup | Neutral |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-14-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-06-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-10-19 | Upgrade | Goldman | Neutral → Buy |
| Apr-23-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Nov-16-18 | Initiated | UBS | Buy |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Jan-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
| Nov-30-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-06-17 | Reiterated | Citigroup | Neutral |
| Nov-01-17 | Reiterated | Mizuho | Buy |
| Jul-26-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-28-17 | Initiated | Argus | Buy |
View All
Hca Healthcare Inc Stock (HCA) Latest News
This Week's Healthcare Earnings: HCA, Roche, And More - Law360
Analyst Jefferies Raises HCA Price Target to $525, Maintains Buy Rating | HCA Stock News - GuruFocus
3 Reasons Growth Investors Will Love HCA (HCA) - sharewise.com
Medline files publicly for IPO - Modern Healthcare News
Jefferies Adjusts Price Target on HCA Healthcare Inc to $525 From $485 - MarketScreener
Is HCA Healthcare Inc. stock oversold or undervaluedJuly 2025 Retail & Weekly High Return Forecasts - Fundação Cultural do Pará
Is HCA HEALTHCARE (HCA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
HCA Healthcare, Inc. (HCA) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Why HCA Healthcare Inc. stock stays on top picksWeekly Investment Recap & Intraday High Probability Setup Alerts - newser.com
What dividend safety score for HCA Healthcare Inc. stockJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com
Is HCA Healthcare Inc. stock overvalued by current metrics2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Is HCA Healthcare Inc. stock vulnerable to regulatory risksMarket Activity Report & Safe Entry Momentum Tips - newser.com
Detecting price anomalies in HCA Healthcare Inc. with AITrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
What macro factors could drive HCA Healthcare Inc. stock higherSell Signal & Technical Pattern Recognition Alerts - newser.com
HCA Stock Quote Price and Forecast - CNN
How HCA Healthcare Inc. stock compares to growth peersEarnings Miss & Community Driven Trade Alerts - newser.com
Is HCA Healthcare Inc. stock ready for a breakoutWeekly Trade Report & Safe Capital Growth Plans - newser.com
Using fundamentals and technicals on HCA Healthcare Inc.Portfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Why retail investors favor HCA Healthcare Inc. stockAnalyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
How geopolitical tensions affect HCA Healthcare Inc. stock2025 Market Overview & Real-Time Buy Signal Notifications - newser.com
How to interpret RSI for HCA Healthcare Inc. stockJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
Why HCA Healthcare Inc. stock could see breakout soonDividend Hike & Long-Term Growth Plans - newser.com
Ranking HCA Healthcare Inc. among high performing stocks via tools2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
HCA Healthcare (HCA) Announces Proposed Public Offering of Senio - GuruFocus
Mizuho Maintains HCA Healthcare (HCA) Outperform Recommendation - Nasdaq
UBS Maintains HCA Healthcare (HCA) Buy Recommendation - Nasdaq
Why HCA Healthcare Inc. (2BH) stock is a must watch tickerTrade Signal Summary & Daily Stock Trend Watchlist - Fundação Cultural do Pará
HCA Healthcare Announces Senior Notes Offering - TipRanks
Is HCA Healthcare Inc. stock attractive for growth fundsPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
HCA Healthcare Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare, Inc. Announces Proposed Public Offering of Senior Notes - TradingView
Key facts: Analysts raise HCA Healthcare price targets; company proposes note offering - TradingView
Portfolio Recap: Can HCA Healthcare Inc. stock hit analyst price targetsInsider Buying & Technical Analysis for Trade Confirmation - Fundação Cultural do Pará
Leerink Partners raises HCA Healthcare stock price target to $470 By Investing.com - Investing.com South Africa
HCA Healthcare (HCA) Sees Raised Price Target by B of A Securities | HCA Stock News - GuruFocus
HCA Healthcare (HCA) Sees Price Target Raised by Goldman Sachs | - GuruFocus
HCA: TD Cowen Raises Price Target to $490 with Buy Rating | HCA Stock News - GuruFocus
HCA raises 2025 guidance, but eyes looming headwinds - Healthcare Dive
RBC Capital Raises Price Target for HCA Healthcare to $482.00 | - GuruFocus
Barclays Raises Price Target for HCA Healthcare (HCA) to $494 | - GuruFocus
Analyst Stephens & Co. Raises HCA Price Target to $500 | HCA Sto - GuruFocus
Truist Securities Raises Price Target for HCA to $495, Maintains Buy Rating | HCA Stock News - GuruFocus
HCA Healthcare Analysts Increase Their Forecasts After Upbeat Q3 Earnings - Benzinga
Earnings Summary: HCA Healthcare Q3 adj. profit jumps on strong revenue growth - AlphaStreet
HCA Healthcare stock price target raised to $482 from $449 at RBC Capital - Investing.com
HCA Stock: Mizuho Raises Price Target to $505, Rating Maintained - GuruFocus
Oppenheimer Raises Price Target for HCA to $500, Maintains Outpe - GuruFocus
HCA announces proposed public offering of senior notes - MarketScreener
HCA Healthcare stock rises as Bernstein reiterates Market Perform rating - Investing.com
HCA Healthcare stock price target raised to $475 by KeyBanc - Investing.com
Using Python tools to backtest HCA Healthcare Inc. strategiesWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Hca Healthcare Inc Stock (HCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.34%
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):